Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Neoplasms × ADI PEG20 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 7 Melanoma 4 Uveal Melanoma 3 Leukemia, Myeloid, Acute 3 Glioblastoma 3 Neoplasms 2 Mesothelioma, Malignant 2 Glioma 2 Carcinoma, Non-Small-Cell Lung 2 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Resectable Hepatocellular Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Ichthyosis, X-Linked 1 HER2 Negative Metastatic Breast Cancer 1 Colorectal Neoplasms 1 Carcinoma 1 Advanced Solid Cancers 1 Advanced Pancreatic Cancer 1

Interventions

Sorafenib 61 Bevacizumab 37 Oxaliplatin 25 Fluorouracil 21 Doxorubicin 19 Gemcitabine 18 Nivolumab 17 pembrolizumab 16 durvalumab 16 Radiosurgery 16 Radiofrequency Ablation 16 Cisplatin 16 lenvatinib 15 Leucovorin 14 Capecitabine 14 atezolizumab 12 Hepatectomy 12 Radiotherapy 11 Irinotecan 10 Cyclophosphamide 10 tremelimumab 9 Carboplatin 9 Blood Specimen Collection 9 Liver Transplantation 8 Ipilimumab 8 Drug Therapy 8 Cryosurgery 8 Chemotherapy, Adjuvant 8 fludarabine 7 Melphalan 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02006030 2018-09-04

TACE

Polaris Group

Phase 2 Completed

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡